Navigation Links
MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director
Date:1/30/2013

SAN DIEGO, Jan. 30, 2013 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Professor Bryan R.G. Williams , Ph.D., will not stand for re-election to MEI Pharma's Board of Directors upon the expiration of his term at the Company's next Annual Meeting of Stockholders. Professor Williams has been a member of the Board since March 2006 and has served as Chairman since November 2006.

(Logo: http://photos.prnewswire.com/prnh/20120628/LA32362LOGO)

"It has been a tremendous experience working with the Board and management team of MEI Pharma," said Professor Williams. "My decision to retire from the Board is driven in part by my increasing responsibilities as Director of the Monash Institute of Medical Research in Melbourne. I also believe that this is the right time to hand over the leadership of the Board to a successor with extensive drug development experience as the Company advances its drug candidates into later stage clinical testing. I wish the Company and its shareholders continued success in the future."

"It has been a pleasure and a great honor to have served with Bryan," said Daniel P. Gold , Ph.D., President and Chief Executive Officer of MEI Pharma. "Bryan's leadership on the board was critical during the Company's transition from R&D to clinical development and he has been a source of strength for our Board over the course of the past seven years. On behalf of all of us, I would like to thank him for the significant contributions he has made to the Company. I am confident that we will find a qualified and proven successor as Chairman to help us continue in the stra
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... 2011 /PRNewswire-iReach/ --  Janet R. Dees, CEO/President of ... opening of its newest vascular access center in Columbus, ... success for American Vascular Access, LLC., and the addition ... R. Dees, CEO/President.   "Our goal has continued ...
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a ... of its CLS® Brevius ™ Hip Stem with ... new technology enables surgeons to better match patients, individual ... adjustments. "Following its introduction in Europe earlier ...
Cached Medicine Technology:American Vascular Access Continues Growth in Georgia 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 3
(Date:4/17/2014)... have called for more research to be carried ... in sub-Saharan Africa. In a paper in ... Stothard, working with colleagues in the department of ... in Cleveland Ohio, University of Cambridge and the ... the joint burden of HIV/AIDS and schistosomiasis of ...
(Date:4/16/2014)... GROVE, Ill. April 16, 2014 According to ... colonoscopy in average-risk patients with one to two small ... percent of cases. This may be an appropriate target ... database study to quantify adherence to guidelines for timing ...
(Date:4/15/2014)... the RECIST Working Group published in the European Journal ... refined categorization of tumor response or various aspects of progression ... They found that modeling target lesion tumor growth did ... that of the other components of progression. The RECIST Working ...
(Date:4/14/2014)... , Alexandria, Va., USA The International and American ... titled "Rare Bone Diseases and Their Dental, Oral, and ... Akintoye, Andrea B. Burke, Alison M. Boyce, Michael Collins, ... Mary Scott Ramnitz, Martha J. Somerman and J. Timothy ...
(Date:4/14/2014)... ,, DALLAS April 14, 2014 Popular web ... lay people to read and doesn,t address the appropriate ... UT Southwestern Medical Center gastroenterologists suggests. , In a ... online patient education materials for colorectal cancer screening were ...
Breaking Medicine News(10 mins):Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Rare bone diseases and their dental, oral and craniofacial manifestations 2Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3
... ... videos out today to support TacheBack - the fundraiser asking men to grow a ,tache in ... Everyman - the UK,s leading male cancer campaign - which launched TacheBack in 2003. , ... (PRWeb UK) 13 August, 2009 -- TV personality ...
... ... of voice technology for the NHS, has today announced that following an extensive tender ... along with 5 other providers for the provision of digital dictation workflow software and ... ...
... ... Angeles has been legalizing medical cannabis. Medical cannabis is, of course, already legalized; ... against medical cannabis have hampered any growth in this industry. , ... (PRWEB) August 13, 2009 -- One ...
... , GRAND RAPIDS, Mich., Aug. 13 The number ... Although younger people have experienced the steepest declines, all age groups ... Cancer Research , a journal of the American Association for Cancer ... including prevention, early detection and better treatment, have resulted in profound ...
... , , , , ... US, Inc. ("Astellas") announced today an update regarding the status of ... Food and Drug Administration,s (FDA) decision regarding its Citizen Petition. The ... Washington, D.C. The company is disappointed in the court,s decision and ...
... , ISELIN, N.J., Aug. 12 Pharmos Corporation (Pink ... ended June 30, 2009. , , Second Quarter Ended ... net loss of $2.3 million, or $0.05 per share, for the second quarter ... in the second quarter 2008. Cash and cash equivalents totaled $2.9 million at ...
Cached Medicine News:Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 2Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 3Health News:"Being a Proper Man is About Having a 'tache" Says Keith Lemon 4Health News:Yorkshire and Humber NHS Procurement Hub Selects BigHand Voice Platform 2Health News:Los Angeles Medical Cannabis Classes Available 2Health News:Cancer Mortality Rates Experience Steady Decline 2Health News:Cancer Mortality Rates Experience Steady Decline 3Health News:Cancer Mortality Rates Experience Steady Decline 4Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 2Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 3Health News:Update on Astellas' Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications 4Health News:Pharmos Corporation Reports 2009 Second Quarter Results 2Health News:Pharmos Corporation Reports 2009 Second Quarter Results 3Health News:Pharmos Corporation Reports 2009 Second Quarter Results 4Health News:Pharmos Corporation Reports 2009 Second Quarter Results 5Health News:Pharmos Corporation Reports 2009 Second Quarter Results 6Health News:Pharmos Corporation Reports 2009 Second Quarter Results 7Health News:Pharmos Corporation Reports 2009 Second Quarter Results 8Health News:Pharmos Corporation Reports 2009 Second Quarter Results 9
... System gets the job done and ... with a review rate far lower ... accurate, physicians are more confident and ... 120 Hematology System, for great performance, ...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
Medicine Products: